GH Research Statistics
Total Valuation
GH Research has a market cap or net worth of $1.49 billion. The enterprise value is $1.22 billion.
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
GH Research has 68.61 million shares outstanding. The number of shares has increased by 15.91% in one year.
| Current Share Class | 68.61M |
| Shares Outstanding | 68.61M |
| Shares Change (YoY) | +15.91% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 24.47% |
| Owned by Institutions (%) | 36.94% |
| Float | 22.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.11 |
| P/TBV Ratio | 5.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.04, with a Debt / Equity ratio of 0.00.
| Current Ratio | 23.04 |
| Quick Ratio | 22.63 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -180.69 |
Financial Efficiency
Return on equity (ROE) is -19.67% and return on invested capital (ROIC) is -14.50%.
| Return on Equity (ROE) | -19.67% |
| Return on Assets (ROA) | -13.99% |
| Return on Invested Capital (ROIC) | -14.50% |
| Return on Capital Employed (ROCE) | -25.31% |
| Weighted Average Cost of Capital (WACC) | 11.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$772,781 |
| Employee Count | 73 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +97.45% in the last 52 weeks. The beta is 1.28, so GH Research's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | +97.45% |
| 50-Day Moving Average | 17.51 |
| 200-Day Moving Average | 14.95 |
| Relative Strength Index (RSI) | 60.41 |
| Average Volume (20 Days) | 230,410 |
Short Selling Information
The latest short interest is 2.15 million, so 3.13% of the outstanding shares have been sold short.
| Short Interest | 2.15M |
| Short Previous Month | 2.15M |
| Short % of Shares Out | 3.13% |
| Short % of Float | 9.34% |
| Short Ratio (days to cover) | 9.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.67M |
| Pretax Income | -56.41M |
| Net Income | -56.41M |
| EBITDA | -66.58M |
| EBIT | -66.67M |
| Earnings Per Share (EPS) | -$0.91 |
Full Income Statement Balance Sheet
The company has $267.33 million in cash and $432,000 in debt, with a net cash position of $266.89 million or $3.89 per share.
| Cash & Cash Equivalents | 267.33M |
| Total Debt | 432,000 |
| Net Cash | 266.89M |
| Net Cash Per Share | $3.89 |
| Equity (Book Value) | 263.38M |
| Book Value Per Share | 4.25 |
| Working Capital | 260.42M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$45.65 million and capital expenditures -$180,000, giving a free cash flow of -$45.83 million.
| Operating Cash Flow | -45.65M |
| Capital Expenditures | -180,000 |
| Depreciation & Amortization | 92,000 |
| Net Borrowing | -267,000 |
| Free Cash Flow | -45.83M |
| FCF Per Share | -$0.67 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GH Research does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.91% |
| Shareholder Yield | -15.91% |
| Earnings Yield | -3.79% |
| FCF Yield | -3.08% |
Analyst Forecast
The average price target for GH Research is $40.13, which is 85.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.13 |
| Price Target Difference | 85.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |